• Drive success in the increasingly complex healthcare environment

  • Every stakeholder in the New Health needs more evidence to improve outcomes and reduce costs. Quintiles is your partner for success.

    • Deep expertise in the challenges of diverse stakeholders – from drug development to disease management to risk mitigation
    • Data analytics lead to insights for more informed decisions
    • Therapeutic expertise in every major area
    • Fully integrated services around the globe

  • Our Perspectives

    slider image

    EIU Emerging China

    This Economist Intelligence Unit study, sponsored by Quintiles, looks at China’s growing pharmaceutical market and its implications for the global life sciences sector. Read white paper here

    slider image

    Lifecycle Modeling and Simulation

    Modeling and simulation is poised to transform drug development across the entire lifecycle from discovery to commercialization. Read white paper here

    slider image

    Integration of Molecular Biomarkers into Clinical Development

    Quintiles experts in strategic drug development recommend using biomarkers in anti-cancer therapy research.  Read white paper here

  •  
     

    Video Spotlights 

  • Data driven insights inform decision making and increase predictability

    Quintiles
    We work with healthcare stakeholders – from biopharma to payers to providers – to see the best path forward.

    Gather the evidence you need to support your decisions with new real-world approaches.   Learn more

    Proving comparative effectiveness is rewriting the path of drug development. Read more

  • Featured News

    Quintiles Rated Industry Leader and Highest in Service Quality in Phase II/III Clinical Research
    Read more

    Quintiles Announces Completion of Initial Public Offering of 27,236,841 Shares of Common Stock
    Read more

    Quintiles Announces Pricing of Initial Public Offering
    Read more

    Our Perspectives

    Harnessing the Power of the Digital Patient White Paper
    Read more

    Tomorrow’s Path to Improved Early-Phase Oncology Drug Development
    Read more

    Strategic Portfolio Management & New Influencers in R&D Decision-Making
    Read more